Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.51 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.51 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053182 | 0.87 | CA1 (0.61) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500198 | 0.85 | CA1 (0.59) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500871 | 0.80 | CA1 (0.53) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500219 | 0.79 | CA1 (0.56) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL14342321 | 0.77 | CA1 (0.41) | CA1CA2PDE3A | |
| SCHEMBL596933 | 0.77 | PDE3A (0.50) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053147 | 0.76 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL12589681 | 0.76 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053161 | 0.76 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053159 | 0.76 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106031-B2 | Hydrolytically-resistant boron-containing therapeutics and methods of use | ANACOR PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |